Extracorporeal life support: Utilization, cost, controversy, and ethics of trying to Save lives

Sheri Crow, Anne C. Fischer, Raquel M. Schears

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

Since the first successful application of extracorporeal membrane oxygenation (ECMO) in 1972, ECMOg's role in the management of respiratory and circulatory collapse continues to be refined and debated. Randomized clinical trials aimed at establishing efficacy and patient selection criteria have been fraught with ethical challenges. Growing concerns over rising health care costs require that careful evaluations of cost, utilization, and ethical issues surrounding heroic life-saving interventions such as ECMO are undertaken. Continued analyses of ECMOg's place in the medical management of respiratory and circulatory failure will help ensure that ECMO is used for not only prolonging life but also for providing a chance for "quality of life" following recovery from near-fatal illnesses.

Original languageEnglish (US)
Pages (from-to)183-191
Number of pages9
JournalSeminars in Cardiothoracic and Vascular Anesthesia
Volume13
Issue number3
DOIs
StatePublished - Sep 1 2009

    Fingerprint

Keywords

  • Extracorporeal Life Support Organization (ELSO)
  • Extracorporeal life support
  • Extracorporeal membrane oxygenation (ECMO)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this